Literature DB >> 31828414

Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.

Minjae Kim1, So Yeong Jung1, Ji Eun Park2, Yeongheun Jo3, Seo Young Park4, Soo Jung Nam5, Jeong Hoon Kim3, Ho Sung Kim1.   

Abstract

OBJECTIVES: To determine whether diffusion- and perfusion-weighted MRI-based radiomics features can improve prediction of isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in lower grade gliomas (LGGs)
METHODS: Radiomics features (n = 6472) were extracted from multiparametric MRI including conventional MRI, apparent diffusion coefficient (ADC), and normalized cerebral blood volume, acquired on 127 LGG patients with determined IDH mutation status and grade (WHO II or III). Radiomics models were constructed using machine learning-based feature selection and generalized linear model classifiers. Segmentation stability was calculated between two readers using concordance correlation coefficients (CCCs). Diagnostic performance to predict IDH mutation and tumor grade was compared between the multiparametric and conventional MRI radiomics models using the area under the receiver operating characteristics curve (AUC). The models were tested using a temporally independent validation set (n = 28).
RESULTS: The multiparametric MRI radiomics model was optimized with a random forest feature selector, with segmentation stability of a CCC threshold of 0.8. For IDH mutation, multiparametric MR radiomics showed similar performance (AUC 0.795) to the conventional radiomics model (AUC 0.729). In tumor grading, multiparametric model with ADC features showed higher performance (AUC 0.932) than the conventional model (AUC 0.555). The independent validation set showed the same trend with AUCs of 0.747 for IDH prediction and 0.819 for tumor grading with multiparametric MRI radiomics model.
CONCLUSION: Multiparametric MRI radiomics model showed improved diagnostic performance in tumor grading and comparable diagnostic performance in IDH mutation status, with ADC features playing a significant role. KEY POINTS: • The multiparametric MRI radiomics model was comparable with conventional MRI radiomics model in predicting IDH mutation. • The multiparametric MRI radiomics model outperformed conventional MRI in glioma grading. • Apparent diffusion coefficient played an important role in glioma grading and predicting IDH mutation status using radiomics.

Entities:  

Keywords:  Glioma; Isocitrate dehydrogenase; Machine learning; Magnetic resonance imaging; Neoplasm grading

Mesh:

Substances:

Year:  2019        PMID: 31828414     DOI: 10.1007/s00330-019-06548-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  43 in total

1.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

2.  Radiomics strategy for glioma grading using texture features from multiparametric MRI.

Authors:  Qiang Tian; Lin-Feng Yan; Xi Zhang; Xin Zhang; Yu-Chuan Hu; Yu Han; Zhi-Cheng Liu; Hai-Yan Nan; Qian Sun; Ying-Zhi Sun; Yang Yang; Ying Yu; Jin Zhang; Bo Hu; Gang Xiao; Ping Chen; Shuai Tian; Jie Xu; Wen Wang; Guang-Bin Cui
Journal:  J Magn Reson Imaging       Date:  2018-03-23       Impact factor: 4.813

3.  A reproducible evaluation of ANTs similarity metric performance in brain image registration.

Authors:  Brian B Avants; Nicholas J Tustison; Gang Song; Philip A Cook; Arno Klein; James C Gee
Journal:  Neuroimage       Date:  2010-09-17       Impact factor: 6.556

4.  MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.

Authors:  Javier E Villanueva-Meyer; Matthew D Wood; Byung Se Choi; Marc C Mabray; Nicholas A Butowski; Tarik Tihan; Soonmee Cha
Journal:  AJR Am J Roentgenol       Date:  2017-12-20       Impact factor: 3.959

5.  Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Authors:  Gregory Cairncross; Meihua Wang; Edward Shaw; Robert Jenkins; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperriere; Walter Curran; Minesh Mehta
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

6.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.

Authors:  Meng Law; Stanley Yang; James S Babb; Edmond A Knopp; John G Golfinos; David Zagzag; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

7.  Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting.

Authors:  Gisele B Caseiras; Sophie Chheang; James Babb; Jeremy H Rees; Nicole Pecerrelli; Daniel J Tozer; Christopher Benton; David Zagzag; Glyn Johnson; Adam D Waldman; H R Jäger; Meng Law
Journal:  Eur J Radiol       Date:  2009-02-06       Impact factor: 3.528

8.  Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.

Authors:  Forrest W Crawford; Inas S Khayal; Colleen McGue; Suja Saraswathy; Andrea Pirzkall; Soonmee Cha; Kathleen R Lamborn; Susan M Chang; Mitchel S Berger; Sarah J Nelson
Journal:  J Neurooncol       Date:  2008-11-15       Impact factor: 4.130

9.  The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.

Authors:  Martinus P G Broen; Marion Smits; Maarten M J Wijnenga; Hendrikus J Dubbink; Monique H M E Anten; Olaf E M G Schijns; Jan Beckervordersandforth; Alida A Postma; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 13.029

10.  Statistical normalization techniques for magnetic resonance imaging.

Authors:  Russell T Shinohara; Elizabeth M Sweeney; Jeff Goldsmith; Navid Shiee; Farrah J Mateen; Peter A Calabresi; Samson Jarso; Dzung L Pham; Daniel S Reich; Ciprian M Crainiceanu
Journal:  Neuroimage Clin       Date:  2014-08-15       Impact factor: 4.881

View more
  32 in total

1.  A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.

Authors:  Shiman Wu; Xi Zhang; Wenting Rui; Yaru Sheng; Yang Yu; Yong Zhang; Zhenwei Yao; Tianming Qiu; Yan Ren
Journal:  Eur Radiol       Date:  2022-02-08       Impact factor: 5.315

2.  RP-Rs-fMRIomics as a Novel Imaging Analysis Strategy to Empower Diagnosis of Brain Gliomas.

Authors:  Xiaoxue Liu; Jianrui Li; Qiang Xu; Qirui Zhang; Xian Zhou; Hao Pan; Nan Wu; Guangming Lu; Zhiqiang Zhang
Journal:  Cancers (Basel)       Date:  2022-06-07       Impact factor: 6.575

Review 3.  Surgical Neuro-Oncology: Management of Glioma.

Authors:  Dana Mitchell; Jack M Shireman; Mahua Dey
Journal:  Neurol Clin       Date:  2022-03-31       Impact factor: 3.787

4.  Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics.

Authors:  Qian Li; Fei Dong; Biao Jiang; Minming Zhang
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

Review 5.  The application of radiomics in predicting gene mutations in cancer.

Authors:  Yana Qi; Tingting Zhao; Mingyong Han
Journal:  Eur Radiol       Date:  2022-01-20       Impact factor: 5.315

6.  CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing.

Authors:  Laura Mancini; Stefano Casagranda; Guillaume Gautier; Philippe Peter; Bruno Lopez; Lewis Thorne; Andrew McEvoy; Anna Miserocchi; George Samandouras; Neil Kitchen; Sebastian Brandner; Enrico De Vita; Francisco Torrealdea; Marilena Rega; Benjamin Schmitt; Patrick Liebig; Eser Sanverdi; Xavier Golay; Sotirios Bisdas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-14       Impact factor: 10.057

7.  Noninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic Review.

Authors:  A P Bhandari; R Liong; J Koppen; S V Murthy; A Lasocki
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-26       Impact factor: 3.825

Review 8.  Accuracy of Machine Learning Algorithms for the Classification of Molecular Features of Gliomas on MRI: A Systematic Literature Review and Meta-Analysis.

Authors:  Evi J van Kempen; Max Post; Manoj Mannil; Benno Kusters; Mark Ter Laan; Frederick J A Meijer; Dylan J H A Henssen
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

9.  Predictive Role of the Apparent Diffusion Coefficient and MRI Morphologic Features on IDH Status in Patients With Diffuse Glioma: A Retrospective Cross-Sectional Study.

Authors:  Jun Zhang; Hong Peng; Yu-Lin Wang; Hua-Feng Xiao; Yuan-Yuan Cui; Xiang-Bing Bian; De-Kang Zhang; Lin Ma
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

10.  MRI-Based Radiomics Models for Predicting Risk Classification of Gastrointestinal Stromal Tumors.

Authors:  Haijia Mao; Bingqian Zhang; Mingyue Zou; Yanan Huang; Liming Yang; Cheng Wang; PeiPei Pang; Zhenhua Zhao
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.